France Épargne Corporate
Claret Capital Partners
Claret Capital Partners is an independent growth debt fund manager based in London. It finances European companies in technology, life sciences and climate tech, including French companies such as Carvolix.
Criteria
Criteria published by the lender
- Instruments
- Not published
- Borrower ownership
- Not published
- Size bands
- Not published
- Accepted collateral
- Not published
- Sharia-compliant structures
- Not published
- Sectors
- Technology, Life sciences, Climate tech
- Exclusions
- Not published
- Lender website
- claret-capital.com
Profile checked on 26 October 2026 against the sources listed at the bottom of the page.
Deals
Published deals
| Announced | Borrower | Purpose | Amount | Instruments | Lenders |
|---|---|---|---|---|---|
| August 2026 | CarvolixA French medical technology company listed on Euronext Paris and based in Aix-en-Provence, formerly Affluent Medical, which develops AI-driven mini robots and biomimetic implants for cardiology. | Growth | €30m | Senior debt | Claret Capital Partners |
| June 2026 | InventivaA clinical stage biopharmaceutical company based in Daix, developing oral treatments for metabolic dysfunction associated steatohepatitis (MASH). | Refinancing | €130m | Senior debt | BlackRock, Claret Capital Partners |
Contact
Request an introduction to lenders
How the database is built
The lender database draws on the information that lenders, borrowers and their shareholders publish on their websites, in their announcements and in regulator registers. Information missing from these sources reads “Not published”. A lender can have its profile corrected or completed through the contact form.